Picture of Kainos Laboratories logo

4556 — Kainos Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMicro CapNeutral

Table: Kainos -2023/24 parent results

May 9 (Reuters)- 
          Kainos Laboratories Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           5.06            4.92           5.40          2.65    
               (+2.7 pct)      (+6.7 pct)     (+6.8 pct)    (+6.5 pct) 
  Operating      865 mln         821 mln        800 mln      400 mln   
               (+5.4 pct)      (+9.8 pct)     (-7.5 pct)   (-22.7 pct) 
  Recurring      928 mln         853 mln        800 mln      400 mln   
               (+8.7 pct)      (+9.8 pct)     (-13.8 pct)  (-23.8 pct) 
  Net            637 mln         568 mln        550 mln      275 mln   
               (+12.3 pct)     (+10.9 pct)    (-13.8 pct)  (-25.7 pct) 
  EPS          152.26 yen      136.13 yen     131.26 yen    65.63 yen  
  Ann Div       32.00 yen       25.00 yen      32.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       32.00 yen       25.00 yen      32.00 yen               
  
  NOTE - Kainos Laboratories Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T

Recent news on Kainos Laboratories

See all news